Skip to content

Humidified High Flow Nasal Cannula Versus Nasal Intermittent Positive Ventilation in Neonates

Humidified High Flow Nasal Cannula Versus Nasal Intermittent Positive Ventilation in Neonates as Primary Respiratory Support:a Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02499744
Enrollment
200
Registered
2015-07-16
Start date
2016-02-29
Completion date
2017-05-31
Last updated
2016-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Insufficiency

Keywords

NIPPV, HHFNC, RDS, neonate

Brief summary

The investigators hypothesize that the Humidified High Flow Nasal Cannula(HHFNC) is effective and safe as primary respiratory support in neonate with respiratory distress syndrome(RDS). It is more convenient in HHFNC combined with kangaroo care.

Detailed description

Today a new nursing principle proposed that is kangaroo care in neonate.Many study showed kangaroo care may reduce pain、decrease the respiratory and heart rate among preterm infant.The recently study show it benefit to Physical Growth and Neurodevelopment. Respiratory failure remains a common problem in the neonatal intensive unit. As reported that early non-invasive ventilation is accompanied by significant improvement in subsequent lung development and alveolation.Nasal continuous positive airway pressure (NCPAP)、nasal intermittent positive pressure ventilation(NIPPV) and humidified high flow via nasal cannulas(HHFNC) are non-invasive ventilation models.But Unfortunately, NIPPV and NCPAP systems are not always easily applied or tolerated in the preterm infants.So it is not convenient in kangaroo care.Recently A meta analysis concluded that NIPPV is more effective than NCPAP in preterms respiratory diseases.Maybe the investigators can reason that NIPPV is effective than HHFNC,but there is limited data about the comparison of NIPPV and HHFNC as primary respiratory support in neonate. The NIPPV group fail definition:1、FiO2\>40%、MAP\>10 centimeter water column (cm H2O),but SaO2\<90%.2、significant abdominal distension.3、PaCO2\>60 millimeter of mercury (mmHg)or partial pressure of arterial oxygen (PaO2)\<45mmHg.4、severe apnea( definition:\>6 episodes requiring stimulation in 6 hours or requiring \>1 episodes of positive-pressure ventilation) 5.potential of hydrogen (PH)\<7.2 The HHFNC group fail definition:1、FiO2\>40%、flow\>8 (litre,L)/min,but SaO2\<90%.2、significant abdominal distension.3、PaCO2\>60mmHg or PaO2\<45mmHg.4、severe apnea 5.PH\<7.2

Interventions

DEVICENIPPV

For infants in the NIPPV-group who failNIPPV (see definition below), need immediate intubation, a invasive Rescue-Treatment may be provided. The decision to attempt Rescue-Treatment, the mode of respiratory support and the ventilator settings used are at the discretion of the attending clinician.

DEVICEHHFNC

For infants in the HHFNC-group who failHHFNC (see definition below), need immediate intubation, a invasive Rescue-Treatment may be provided. The decision to attempt Rescue-Treatment, the mode of respiratory support and the ventilator settings used are at the discretion of the attending clinician.

Sponsors

Gao WeiWei
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 28 Days
Healthy volunteers
No

Inclusion criteria

1. Birth weight \> 1000 grams and \> 28 weeks gestation 2. have respiratory distress syndrome and need assistant ventilation

Exclusion criteria

1. Birth weight \< 1000 grams 2. Estimated gestation \< 28 weeks 3. infants have contraindications for use of non-invasive ventilation 4. Active air leak syndrome 5. Infants with abnormalities of the upper and lower airways; such as Pierre- Robin, Treacher-Collins, Goldenhar, choanal atresia or stenosis, cleft lip and/or palate, or 6. Infants with significant abdominal or respiratory malformations including trachea-esophageal fistula, intestinal atresia, omphalocele, gastroschisis, and congenital diaphragmatic hernia.

Design outcomes

Primary

MeasureTime frameDescription
endotracheal intubation rate3 daysendotracheal intubation rate assessed within 72 hours after extubation

Secondary

MeasureTime frameDescription
Bronchopulmonary dysplasia3 monthsBronchopulmonary dysplasia assessed by national institute of child health and human development(NICHD) definition
necrotizing enterocolitis3 monthsnecrotizing enterocolitis assessed by abdominal X-ray and Bell classification
significant apnea7 dayssignificant apnea measured by the Colin J definition:6 episodes requiring stimulation in 6 hours or requiring\>1 episodes of positive -pressure ventilation
duration of non-invasive ventilation3 monthsthe duration of ventilation measured by total non-invasive ventilation time in HHFNC and NIPPV groups
full enteral feeding3 monthsfull enteral feeding measured by total feeding dose above 120 ml per kilogram one day
nasal trauma3 monthsnasal trauma measured by US national pressure Ulcer Advisory Panel(NPUAP)
air leaks3 monthsair leak assessed by chest X-ray

Other

MeasureTime frameDescription
pain score3 monthspain score assessed by neonatal infant pain scale (NIPS)
neurodevelopment3 monthsneurodevelopment assessed by Bayley scale

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026